Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: ease... so let's take the chance..:-)

"I am very confident the vast majority of shareholders would back a move against Alliacense to have a good chance of obtaining better terms."

Another 100% agreement - we have to be realistic: there's a better chance to improve the conditions with TPL et al than to get rid of them.

I would prefer we could discuss if there are any possibilities for us shareholders to back a move from PTSC.

GLTY

Share
New Message
Please login to post a reply